Forma

A Legacy in the Making: The Global Ambassador Solidifies its Place Among Arizona's Luxury Set

Retrieved on: 
Wednesday, December 6, 2023

PHOENIX, Dec. 6, 2023 /PRNewswire-PRWeb/ -- Very few hotels today are the culmination of a deeply personal journey of one individual – an individual who, bound by no brand, has dedicated close to a decade scrutinizing every singular detail of the guest experience, from the way the shower door swings to how the morning light plays on the sumptuous fabric wallcoverings, and everything in between.

Key Points: 
  • The Global Ambassador is a convergence of hospitality, wellness, culinary and culture – it has become my legacy project," said Fox.
  • The hotel's formidable restaurant lineup boasts five original concepts, including the state's largest rooftop dining experience with unmatched Camelback Mountain views.
  • The Global Ambassador stands in a class all its own amidst the area's prestigious luxury hotel landscape.
  • The Global Ambassador is a convergence of hospitality, wellness, culinary and culture – it has become my legacy project."

OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs

Retrieved on: 
Wednesday, September 20, 2023

BOULDER, Colo., Sept. 20, 2023 (GLOBE NEWSWIRE) -- OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next generation of oncology precision medicines, today announced the appointment of Ann Howell as Vice President of Regulatory Affairs.

Key Points: 
  • BOULDER, Colo., Sept. 20, 2023 (GLOBE NEWSWIRE) -- OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next generation of oncology precision medicines, today announced the appointment of Ann Howell as Vice President of Regulatory Affairs.
  • Dr. Howell brings an abundance of experience managing regulatory affairs activities for both small and large biopharmaceutical companies, with global regulatory responsibilities across a variety of therapeutic areas, including oncology.
  • “We are delighted to welcome Ann to the OnKure team,” said Tony Piscopio, Ph.D., Co-Founder, President and Chief Executive Officer of OnKure.
  • “Ann has an impressive background in leading the regulatory strategies for numerous product developments and subsequent NDA submissions, in addition to expertise overseeing global regulatory interactions for oncology development projects.

uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

Retrieved on: 
Tuesday, August 1, 2023

and AMSTERDAM, Aug. 01, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial results for the second quarter of 2023 and highlighted recent progress across its business.

Key Points: 
  • and AMSTERDAM, Aug. 01, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial results for the second quarter of 2023 and highlighted recent progress across its business.
  • The Company continues to make progress enrolling the second, high-dose cohort of nine patients and expects to complete enrollment in the third quarter of 2023.
  • The Company expects to initiate a Phase I/II clinical study of AMT-162 in the second half of 2023.
  • The Company expects cash, cash equivalents and investment securities will fund operations into the second quarter of 2026.

Luxury Skincare Brand COSMEDIX Announces Julia Estrella as New National Sales Director

Retrieved on: 
Tuesday, May 23, 2023

ATLANTA, May 23, 2023 /PRNewswire-PRWeb/ -- COSMEDIX, a brand best known for their clean and clinical skincare, has announced the appointment of Julia Estrella as National Sales Director. In this position, Julia will use her in-depth experience to lead and motivate a field team of Account Executives and execute pivotal growth strategies for the brand.

Key Points: 
  • COSMEDIX, a brand best known for their clean and clinical skincare, has announced the appointment of Julia Estrella as National Sales Director.
  • ATLANTA, May 23, 2023 /PRNewswire-PRWeb/ -- COSMEDIX, a brand best known for their clean and clinical skincare, has announced the appointment of Julia Estrella as National Sales Director.
  • Before joining COSMEDIX, Julia served as Director of Field Sales and Education at Tarte Cosmetics where she led a team of seven Regional Directors.
  • The leadership team at COSMEDIX congratulates Julia on this new position and are confident in her ability to excel as National Sales Director.

 Therini Bio Initiates First-In-Human Dosing in Phase 1 Trial of THN391, a Fibrin-Targeting Therapeutic Candidate for Alzheimer’s Disease

Retrieved on: 
Monday, May 15, 2023

“Initiating first-in-human dosing for THN391 is a significant milestone and we’re excited about the approach that Therini Bio is taking towards treating Alzheimer’s disease and other inflammatory neurodegenerative and retinal diseases.

Key Points: 
  • “Initiating first-in-human dosing for THN391 is a significant milestone and we’re excited about the approach that Therini Bio is taking towards treating Alzheimer’s disease and other inflammatory neurodegenerative and retinal diseases.
  • "We are thrilled to announce the initiation of first-in-human dosing for THN391, our fibrin-targeting therapeutic candidate for Alzheimer's disease.
  • “I look forward to working alongside the Therini Bio team to help advance this candidate and its pipeline of fibrin-targeted therapeutic candidates.
  • We are thrilled to have Frank join Therini Bio as Executive Chairperson of the Board, as Therini Bio advances their fibrin-targeting therapeutic candidate for Alzheimer's disease and retinal diseases.

Autodesk Introduces Forma for Next-Generation Building Design in the Cloud

Retrieved on: 
Monday, May 8, 2023

"Forma gives architecture professionals the agility to work iteratively rather than sequentially between planning and detailed design, supercharging what they can accomplish," said Amy Bunszel, Executive Vice President of Architecture, Engineering and Construction Design Solutions at Autodesk.

Key Points: 
  • "Forma gives architecture professionals the agility to work iteratively rather than sequentially between planning and detailed design, supercharging what they can accomplish," said Amy Bunszel, Executive Vice President of Architecture, Engineering and Construction Design Solutions at Autodesk.
  • Forma will help users to rapidly evaluate dozens of design options and improve upon the desired qualities of a design.
  • Conceptual design capabilities offer freeform building design tools for users to creatively express their design intents and create complex designs in full 3D in just minutes.
  • With Forma, Autodesk now offers a full end-to-end solution for building design–from early-stage planning through to design in Revit with its vast ecosystem of connected products including Autodesk Construction Cloud.

Cellarity Strengthens Executive Leadership Team

Retrieved on: 
Tuesday, April 11, 2023

The Cellarity platform uncovers novel actionable biology and creates non-intuitive drug candidates to address a vast array of diseases, even those with either limited or unknown targets.

Key Points: 
  • The Cellarity platform uncovers novel actionable biology and creates non-intuitive drug candidates to address a vast array of diseases, even those with either limited or unknown targets.
  • These new leadership appointments will allow Cellarity to accelerate development of its platform and progress its pipeline programs towards the clinic.
  • “Their appointments are a great complement to the already well experienced senior leadership team which includes Parul Doshi, recently promoted to Chief Data Officer.
  • Prior to joining Cellarity, he was previously Executive Medical Director in Clinical Development at Forma Therapeutics (acquired by Novo Nordisk) where he led their flagship sickle cell disease program.

Snap Inc. Unveils ARES to Bring Power of Its Augmented Reality to Enterprises

Retrieved on: 
Thursday, March 23, 2023

Snap Inc. today unveiled AR Enterprise Services (ARES), a new enterprise solution to enable businesses to integrate Snap's Augmented Reality (AR) into their owned and operated channels with ease and at scale.

Key Points: 
  • Snap Inc. today unveiled AR Enterprise Services (ARES), a new enterprise solution to enable businesses to integrate Snap's Augmented Reality (AR) into their owned and operated channels with ease and at scale.
  • ARES’ inaugural offering is for retail, and among the first group of customers are Goodr, Princess Polly, and Gobi Cashmere.
  • Each of these companies have been using various products from Fit Finder to AR Try-On, which are features that make up our new Shopping Suite.
  • ARES’ Shopping Suite will be widely available to customers in Q2 and includes AR shopping for apparel, footwear, and accessories.

Sickle Cell Disease Association of America to promote clinical trials

Retrieved on: 
Friday, March 17, 2023

HANOVER, Md., March 17, 2023 /PRNewswire-PRWeb/ -- The Sickle Cell Disease Association of America, a national nonprofit membership organization that advocates for people affected by sickle cell, formed the Sickle Cell Disease C.A.R.E.S. Consortium, an initiative of pharmaceutical companies united to promote clinical trial participation and education.

Key Points: 
  • The Sickle Cell Disease Association of America, a national nonprofit membership organization that advocates for people affected by sickle cell, formed the Sickle Cell Disease C.A.R.E.S.
  • HANOVER, Md., March 17, 2023 /PRNewswire-PRWeb/ -- The Sickle Cell Disease Association of America, a national nonprofit membership organization that advocates for people affected by sickle cell, formed the Sickle Cell Disease C.A.R.E.S.
  • "We have an opportunity and a responsibility to change the perception of clinical trials and increase the participation of sickle cell patients in clinical trials," said Regina Hartfield, president and CEO of the Sickle Cell Disease Association of America.
  • Sickle Cell Disease Association of America advocates for people affected by sickle cell conditions and empowers community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.

Editas Medicine Strengthens Executive Leadership Team with Appointment of Linea Aspesi as Chief People Officer

Retrieved on: 
Wednesday, March 8, 2023

CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the appointment of Linea Aspesi as the Company’s Executive Vice President and Chief People Officer.

Key Points: 
  • CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the appointment of Linea Aspesi as the Company’s Executive Vice President and Chief People Officer.
  • Ms. Aspesi will lead Editas’ human resources department and the Company’s people strategy in support of its mission and goals.
  • I look forward to working with Linea and the Leadership Team to help drive our talented team towards our goal of becoming a commercial-stage organization and transforming the lives of people living with serious diseases,” said Gilmore O’Neill, M.B., M.M.Sc., President and Chief Executive Officer, Editas Medicine.
  • I am excited to partner with our Leadership Team and our employees to make an impact in the lives of patients around the world,” said Linea Aspesi, Executive Vice President and Chief People Officer, Editas Medicine.